Madrid, Spain

Cristobal Martinez Roldan


Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1977-1981

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Cristobal Martinez Roldan: Innovator in Analgesic Compounds

Introduction

Cristobal Martinez Roldan is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of analgesic compounds. With a total of 4 patents to his name, Roldan's work has the potential to impact pain management therapies.

Latest Patents

Roldan's latest patents include innovative compounds such as 1,2-Diacylamino-1,2-di(4-pyridyl)ethanes. This patent describes a process for producing these compounds, which are characterized by a general formula where R can be a saturated or unsaturated alkyl group, a homocyclic or heterocyclic aromatic ring, with or without substituents, or a saturated or unsaturated cycloalkyl. These compounds are particularly useful as analgesics. Another significant patent is for 2,5-Dimethyl-benzo[b]-thieno[2,3-f]morphan and its precursors. This invention also focuses on compounds that serve as analgesic agents, showcasing Roldan's commitment to advancing pain relief solutions.

Career Highlights

Throughout his career, Roldan has worked with reputable companies such as Laboratorios Made, S.A. His experience in these organizations has allowed him to refine his skills and contribute to the development of innovative pharmaceutical products.

Collaborations

Roldan has collaborated with notable colleagues, including Miguel Fernandez Brana and Jose Maria Castellano Berlanga. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Cristobal Martinez Roldan is a distinguished inventor whose work in analgesic compounds has the potential to enhance pain management therapies. His contributions through patents and collaborations reflect his dedication to advancing medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…